A carregar...
Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction
Oral phosphodiesterase type 5 (PDE5) inhibitors have provided non-invasive, effective, and well-tolerated treatments for patients with erectile dysfunction (ED). However, many patients with ED are unresponsive to 'on-demand' PDE5 inhibitors. In addition, the lack of spontaneity and natural...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Urological Association
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382685/ https://ncbi.nlm.nih.gov/pubmed/22741044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2012.53.6.377 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|